QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: GVP Module XVI Educational Materials as Additional Risk Minimisation Measures

Test your understanding of the concepts covered by GVP Module XVI: Educational Materials as Additional Risk Minimisation Measures.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Which statement best distinguishes an additional educational measure from routine risk minimisation?

An educational measure replaces the product information for the relevant risk An educational measure is primarily a promotional explanation of product benefits An educational measure addresses a defined residual risk with an additional behavioural or decision-making purpose An educational measure is required whenever a product has any known adverse reaction

Question 2 of 10 What is particularly important when evaluating pregnancy-prevention risk minimisation?

Assessing only whether healthcare professionals received the material Considering the pathway involving professional counselling, patient behaviour, timing of exposure and pregnancy-related outcomes Measuring only general awareness of embryo-fetal risk Treating the educational component as independent of all other prevention measures

Question 3 of 10 A serious risk occurs because prescribers fail to identify a contraindication before initiating treatment. Which objective is most closely aligned with the preventable mechanism?

Increase general awareness of the product's safety profile Improve recognition of the contraindication before prescribing Increase the number of healthcare professionals receiving the brochure Improve knowledge of the product's pharmacological class

Question 4 of 10 How should the target audience for an educational measure primarily be determined?

By selecting the largest possible healthcare professional population By identifying who must perform the action needed to control the risk By targeting only the organisation's existing distribution list By selecting the audience most likely to engage with digital content

Question 5 of 10 Which control is especially important for a digital educational resource?

Allowing multiple uncontrolled versions to remain online Ensuring that current approved content is identifiable and obsolete content is controlled where necessary Removing all regulatory review because digital content can be updated quickly Using the same online channel in every Member State without assessment

Question 6 of 10 Which factor is an example of potential confounding in an outcome-based evaluation?

The approved version number of the material alone A simultaneous regulatory restriction that changes exposure to the medicine The use of headings in the educational document The inclusion of a defined risk-minimisation objective

Question 7 of 10 Before dissemination in a Member State where national review is required, what should the organisation do?

Begin distribution and seek approval retrospectively Obtain the applicable national approval or agreement before implementation Use an uncontrolled digital version while awaiting review Distribute only to a small group without recording the activity

Question 8 of 10 What remains the MAH's responsibility when an external vendor performs distribution or evaluation activities?

Nothing, because operational responsibility has been delegated Only payment of the vendor's invoices Ensuring defined responsibilities, interfaces, escalation, data access and record retention sufficient to oversee and reconstruct performance Allowing the vendor to control the approved content without contractual controls

Question 9 of 10 Which change would most clearly compromise scientific accuracy in an educational material?

Using simpler terminology for a non-specialist audience Reordering instructions so that the required action is easier to find Removing an important qualification and presenting a causal claim more strongly than the evidence supports Using headings and bullet points to improve readability

Question 10 of 10 A document accurately describes an adverse reaction but does not explain what prescribers should do to prevent or manage it. What is the principal weakness?

The material is too scientifically detailed The material lacks a clear connection between information and the required risk-minimising behaviour The material should necessarily be converted into promotional content The material has failed because all educational measures must contain patient information

QPPV.com

Knowledge Assessment: GVP Module XVI Educational Materials as Additional Risk Minimisation Measures

Cookie Settings